Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Cancer Research|August 1, 1993
Main drug-metabolizing enzyme systems in human breast tumors and peritumoral tissuesN Albin, L Massaad, C Toussaint, et al.
British Journal of Cancer|January 22, 2004
Detection of HER-2/neu-positive circulating epithelial cells in prostate cancer patientsN Ady, L Morat, K Fizazi, et al.
Drug Development and Industrial Pharmacy|March 5, 1999
Formulation of a charcoal suspension for intratumoral injection. Study of galenical excipientsL Bonhomme-Faivre, M C Mathieu, P Depraetere, et al.
Cytopathology : Official Journal of the British Society for Clinical Cytology|September 22, 2012
Pure and mixed mucinous carcinoma of the breast: fine needle aspiration cytology findings and review of the literatureJ Cyrta, F Andreiuolo, S Azoulay, et al.
International Journal of Cancer|June 16, 2001
c-erbB-2 (HER-2/neu) gene amplification is a better indicator of poor prognosis than protein over-expression in operable breast-cancer patientsG Riou, M C Mathieu, M Barrois, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 25, 2003
Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasisJ-P Travagli, D Atallah, M-C Mathieu, et al.
Pharmaceutical Research|February 1, 1997
Formulation of a charcoal suspension for intratumor injection. Part 1: Study of the nature, granulometry, and concentrationL Bonhomme-Faivre, M C Mathieu, J L Grossiord, et al.
International Journal of Cancer|November 24, 1999
c-myc, p53 and bcl-2, apoptosis-related genes in infiltrating breast carcinomas: evidence of a link between bcl-2 protein over-expression and a lower risk of metastasis and death in operable patientsM G Lê, M C Mathieu, S Douc-Rasy, et al.
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1996
Strategies for cancer gene therapy using adenoviral vectorsV Descamps, M T Duffour, M C Mathieu, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profileM-C Mathieu, R Rouzier, A Llombart-Cussac, et al.
Pageof 5